38 Million of the 250 million doses ordered by the government are available, but Glaxo said it’s approved vaccine won’t ship until next month. This has been absolutely a fire drill to get supplied out in the US. In the meantime, Glaxo is continuing to close facilities like some of the other manufacturers are doing. BD
The Food and Drug Administration just approved a shot against the new H1N1 virus from GlaxoSmithKline. As a result there are now four companies able to provide swine flu shots in the US. The fifth provider is AstraZeneca's MedImmune unit, whose vaccine is a nasal spray.
None of the vaccines for America, including Glaxo's, contain an adjuvant, or immune-system booster. Those chemicals have never been used in an approved flu vaccine in this country, though they are OK in Europe.
In other related news:
First, we'll look at GlaxoSmithKline's closure of a Stiefel facility in Sligo, Ireland. GSK bought Stiefel, a skincare specialist, in July and has decided to close the small company's headquarters in Florida, shedding some 300 jobs in the process. Now, GSK will pare its payroll by 250 with the shutdown of Stiefel's manufacturing plant in Sligo.